Correlation Between Chemours and Upstream Bio,

Can any of the company-specific risk be diversified away by investing in both Chemours and Upstream Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chemours and Upstream Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Chemours Co and Upstream Bio,, you can compare the effects of market volatilities on Chemours and Upstream Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chemours with a short position of Upstream Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chemours and Upstream Bio,.

Diversification Opportunities for Chemours and Upstream Bio,

0.16

Correlation Coefficient

Chemours  Upstream Bio,

Average diversification

The 3 months correlation between Chemours and Upstream is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Chemours Co and Upstream Bio, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Upstream Bio, and Chemours is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chemours Co are associated (or correlated) with Upstream Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Upstream Bio, has no effect on the direction of Chemours i.e., Chemours and Upstream Bio, go up and down completely randomly.

Pair Corralation between Chemours and Upstream Bio,

Allowing for the 90-day total investment horizon Chemours Co is expected to under-perform the Upstream Bio,. But the stock apears to be less risky and, when comparing its historical volatility, Chemours Co is 3.22 times less risky than Upstream Bio,. The stock trades about -0.62 of its potential returns per unit of risk. The Upstream Bio, is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest  2,220  in Upstream Bio, on October 8, 2024 and sell it today you would lose (385.00) from holding Upstream Bio, or give up 17.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Chemours Co  vs.  Upstream Bio,

Chemours

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Chemours Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Upstream Bio,

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Upstream Bio, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Upstream Bio, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Chemours and Upstream Bio,

The main advantage of trading using opposite Chemours and Upstream Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chemours position performs unexpectedly, Upstream Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Upstream Bio, will offset losses from the drop in Upstream Bio,'s long position.

The idea behind Chemours Co and Upstream Bio, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.